Vanguard Group Inc Poseida Therapeutics, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PSTX
# of Institutions
93Shares Held
38.1MCall Options Held
255KPut Options Held
62K-
Pentwater Capital Management LP Naples, FL5.98MShares$17.6 Million0.2% of portfolio
-
Black Rock Inc. New York, NY4.95MShares$14.6 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.48MShares$13.2 Million0.74% of portfolio
-
Silverarc Capital Management, LLC3.6MShares$10.6 Million3.85% of portfolio
-
Geode Capital Management, LLC Boston, MA1.56MShares$4.6 Million0.0% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $252M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...